Smith, Amelia
Murphy, Laura
Sharp, Linda
O'Connor, Darran
Gallagher, William M
Bennett, Kathleen
Barron, Thomas I
Article History
Received: 12 April 2016
Revised: 1 July 2016
Accepted: 6 July 2016
First Online: 2 August 2016
Competing interests
: LS reports receiving commercial research support from Sanofi-Aventis for a project on treatment and outcomes in breast cancer; 2011–2012. WMG holds a part-time role as Chief Scientific Officer in OncoMark Limited, and was a co-founder and current shareholder of the same. The remaining authors declare no conflict of interest.